FC1C=C(C=CC=1)CO[C:7]1[CH:16]=[CH:15][C:14]2[C:13](=[O:17])[NH:12][CH2:11][CH2:10][C:9]=2[N:8]=1.C(Cl)Cl.[F:24][C:25]1[CH:26]=[C:27](B(O)O)[CH:28]=[CH:29][CH:30]=1>CC([O-])=O.CC([O-])=O.[Cu+2].C(N(CC)CC)C>[F:24][C:25]1[CH:30]=[C:29]([N:12]2[CH2:11][CH2:10][C:9]3[N:8]=[CH:7][CH:16]=[CH:15][C:14]=3[C:13]2=[O:17])[CH:28]=[CH:27][CH:26]=12-((3-fluorobenzyl)oxy)-7,8-dihydro-1,6-naphthyridin-5(6H)-one (30 mg, 0.11 mmol) was dissolved into DCM (2 mL) and treated with 3-fluorophenylboronic acid (30 mg, 0.22 mmol), Cu(OAc)2 (22 mg, 0.13 mmol), and triethylamine (50 μL). The reaction was stirred for 2 days at RT and concentrated to an oil and purified by RP-HPLC (10-90% gradient CH3CN in water with 0.1% TFA modifier) to give the compound, 24(3-fluorobenzyl)oxy)-6-(3-fluorophenyl)-7,8-dihydro-1,6-naphthyridin-5(6H)-one. LC-MS (M+H)=367.2.
読み込み中…
